Corpus Christi, Texas – Corpus Christi Women’s Clinic, a large, full-service women's health practice in Corpus Christi, Texas, has partnered with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients. As a result of this partnership, the practice will expand the treatment options it offers patients by supporting research studies conducted in its practice.
Physicians at Corpus Christi Women’s Clinic who will be participating as lead investigators in the clinical trials include: Charles Kirkham, M.D. (FACOG); Christine L. Canterbury, M.D. (FACOG); Leighanne Glazener, M.D. (FACOG); Jaime Pena, M.D. (FACOG); Benjamin Supnet, M.D. (FACOG); Danielle Inman, M.D. (FACOG); Heather Dixon, D.O.; Thomas Wilder, M.D. (FACOG); and Lindsey Vasquez, M.D. (FACOG).
As members of Elligo’s Research Ready network, Corpus Christi Women’s Clinic now has the infrastructure - people, processes, and technology - necessary to conduct research in its office, effectively keeping patients closer to home and under the care of their trusted physician. The practice’s extension into clinical research will help its patients benefit from treatments they might not otherwise be able to access.
In a statement from Corpus Christi Women’s Clinic, the physicians explained, “We often run into scenarios where we have exhausted all traditional treatment options with our patients. Complete patient care is important to us and this partnership will help ensure we can continue to provide options for even our toughest clinical cases.”
“Our ultimate goal is twofold: to make research accessible and the process simple,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “That’s why we offer our services at no cost to our physician sites. For us, the best part is that with every new site, our ability to contribute to the future of medicine grows.”
About Corpus Christi Women’s Clinic
Corpus Christi Women’s Clinic, a large full-service women’s health physician practice serving Nueces County, opened in August of 1981. We have ten physicians. Between the ten of us, we have delivered more than 40,000 babies in our combined 100 years of experience in the Corpus Christi area. Our Womankind Services offers patients the convenience of complete OB-GYN care, including sonograms, bone density testing, and urodynamics.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.